Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study-Reference-Cited by-同舟云学术

Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study

Published:2020-09 Issue:5 Volume:1 Page:e200-e208
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Chappell Catherine A,Scarsi Kimberly K,Kirby Brian J,Suri Vithika,Gaggar Anuj,Bogen Debra L,Macio Ingrid S,Meyn Leslie A,Bunge Katherine E,Krans Elizabeth E,Hillier Sharon L

Publisher

Elsevier BV

Reference26 articles.

1. Individual state hepatitis C data supports expanding screening beyond baby boomers to all adults;Morse;Gastroenterology,2018

2. Hepatitis C virus infection among women giving birth—Tennessee and United States, 2009–2014;Patrick;MMWR Morb Mortal Wkly Rep,2017

3. National trends in hepatitis C infection by opioid use disorder status among pregnant women at delivery hospitalization—United States, 2000–2015;Ko;MMWR Morb Mortal Wkly Rep,2019

4. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012;Zibbell;MMWR Morb Mortal Wkly Rep,2015

5. Vertical transmission of hepatitis C virus: systematic review and meta-analysis;Benova;Clin Infect Dis,2014

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Screening for viral hepatitis carriage;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-09

3. Hepatitis co-infection in paediatric HIV: progressing treatment and prevention;Current Opinion in HIV and AIDS;2024-07-29

4. Prevalence and Modes of Transmission of Hepatitis C Virus Infection: A Historical Worldwide Review;Viruses;2024-07-11

5. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study;International Journal of Drug Policy;2024-07